📰 Transcode Therapeutics News
Page 6 - Transcode Therapeutics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Transcode Therapeutics. Real-time updates on events, politics, business and more.
June 23, 2023
The Dow Jones closed slightly lower on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
June 17, 2023
TransCode Therapeutics, Inc. (NASDAQ:RNAZ – Get Rating) was the target of a large increase in short interest in May. As of May 31st, there was short interest totalling 27,100 shares, an increase of 22.1% from the May 15th total of 22,200 shares. Currently, 4.4% of the shares of the stock are sold short. Based on […]
June 17, 2023
TransCode Therapeutics, Inc. (NASDAQ:RNAZ – Get Rating) was the target of a large growth in short interest in May. As of May 31st, there was short interest totalling 27,100 shares, a growth of 22.1% from the May 15th total of 22,200 shares. Based on an average daily trading volume, of 162,200 shares, the days-to-cover ratio […]
June 14, 2023
The Dow Jones closed higher by over 140 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
June 13, 2023
TransCode Therapeutics, Inc. (NASDAQ:RNAZ – Get Rating) CEO Robert Michael Dudley purchased 19,000 shares of the firm’s stock in a transaction that occurred on Friday, June 9th. The stock was acquired at an average price of $2.76 per share, with a total value of $52,440.00. Following the completion of the purchase, the chief executive officer […]
June 13, 2023
TransCode Therapeutics, Inc. (NASDAQ:RNAZ – Get Rating) CEO Robert Michael Dudley bought 19,000 shares of the stock in a transaction on Friday, June 9th. The shares were acquired at an average cost of $2.76 per share, for a total transaction of $52,440.00. Following the acquisition, the chief executive officer now directly owns 912,114 shares in […]
June 8, 2023
Vodafone Group was the biggest company on a market cap basis to set a new 52-week low. • The smallest company by market cap to set a new 52-week low was…
May 23, 2023
TransCode Therapeutics, Inc. (RNAZ) shares are gaining more than 7 percent on Tuesday morning trade after reaching a year-to-date low on Monday. The company had announced a 1-for-20 reverse stock split, effective May 22.
May 15, 2023
Clinical Stage Platform Delivery Company Overcoming Intractable Problems in Oncology and Beyond ... | May 15, 2023
May 14, 2023
Terns Pharmaceuticals (NASDAQ:TERN – Get Rating) and TransCode Therapeutics (NASDAQ:RNAZ – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, risk, dividends, institutional ownership, analyst recommendations, earnings and valuation. Insider and Institutional Ownership 15.9% of TransCode Therapeutics shares […]